Lefamulin - Nabriva Therapeutics
At a glance
- Drug Originator Nabriva Therapeutics
- Drug Licenced by Er-Kim Ilac; Sinovant Sciences; Sumitomo Pharmaceuticals; Sunovion Pharmaceuticals Canada
- Drug Class Alkenes; Anti-infectives; Anti-inflammatories; Antibacterials; Antifibrotics; Cyclopentanes; Diterpenes; Polycyclic compounds; Small molecules; Thioglycolates
- Mechanism of Action Immunomodulators; Peptidyltransferase modulators; Protein 50S ribosomal subunit modulators
- USA Patent Applicants NABRIVA
- USA Patents 4
- NDAs 2
- International Patents 86
- Patent Applications 35
Table of Contents

Disclaimer